ASX:BOT

BOTANIX PHARMACEUTICALS LTD

BOTANIX PHARMACEUTICALS LTD has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

< $50k

Investors Interested in Next Raise

< 10

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

30 July 2019

Placement

Raised

$40m

Offer Price

$0.210

Discount

19.23%

Price at Close

$0.260

Market Cap

$201.25m

Re-listed

01-08-2019

Company Overview

Botanix Pharma aims to develop next-generation therapeutics for the treatment of serious skin diseases. The company's mission is to improve the lives of patients battling acne, psoriasis and atopic dermatitis, by providing new treatment options for conditions that currently are inadequately addressed or are treated with therapeutics that are burdened with side effects profiles. The company is developing the potential of a synthetic active pharmaceutical ingredient known as cannabidiol which is currently being studied for the treatment of epilepsy, pain, arthritis and schizophrenia amongst other indications. Botanix is preparing for the first human trials utilizing synthetic cannabidiol in a proprietary drug delivery system (Permetrex™) for direct skin delivery of the therapy.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

68 Aberdeen St, Northbridge WA 6003, Australia

Website

www.botanixpharma.com

Biotechnology

Health Care

Biotech & Health

Price Chart

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.